Cellular quality control process could be Huntington's disease drug target
Monday, February 13, 2017 - 13:31
in Health & Medicine
The loss of motor function and mental acuity associated with Huntington's disease might be treatable by restoring a cellular quality control process, which researchers have identified as a key factor in the degenerative illness.